Germline transmission for ESCs in rats
Tuesday, 02 September, 2008
Two independent labs have demonstrated germline transmission from embryonic stem cells in rats, biotech company Stem Cell Sciences has reported.
The unpublished research, thought to be a world first, used technologies licensed to STC from Edinburgh University.
SCS has global exclusive rights to commercialise the rat ES cells, the specific culture medium used to generate and grow the cells, and rats derived therefrom.
Rats are seen to serve as more predictable human models than mice for several categories of psychiatric, neurological and cardiovascular drug discovery programs.
STC says it will soon begin negotiations with a number of parties seeking a sublicense to use the cells in drug discovery programs.
Turning point — optimal antibiotics for golden staph bloodstream infections
Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports...
Alloy implants that naturally dissolve after healing
Australian researchers have been developing biodegradable magnesium-based alloys that more...
Partnership eyes up gene-editing approaches to vision loss
A partnership will build on Australian ophthalmic research into mechanisms that damage nerve...
